Dec. 24, 2008--The FDA posted on its web site yesterday a letter it sent to Abbott Laboratories about a review of an American Academy of Dermatology (AAD) Post Meeting News Ad for Humira. According to the FDA, "This AAD Post Meeting News Ad broadens the approved indication......
The details can be read here.
No comments:
Post a Comment